128 related articles for article (PubMed ID: 33592126)
1. Antiangiogenic effect of arsenic trioxide in HUVECs by FoxO3a-regulated autophagy.
Sun Z; Cao Y; Xing Y; Wu M; Shao X; Huang Q; Bai L; Wang L; Zhao Y; Wu Y
J Biochem Mol Toxicol; 2021 May; 35(5):e22728. PubMed ID: 33592126
[TBL] [Abstract][Full Text] [Related]
2. Arsenic Trioxide Suppressed Migration and Angiogenesis by Targeting FOXO3a in Gastric Cancer Cells.
Zhang L; Liu L; Zhan S; Chen L; Wang Y; Zhang Y; Du J; Wu Y; Gu L
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477221
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide inhibits angiogenesis in vitro and in vivo by upregulating FoxO3a.
Sun Z; Li M; Bai L; Fu J; Lu J; Wu M; Zhou C; Zhang Y; Wu Y
Toxicol Lett; 2019 Oct; 315():1-8. PubMed ID: 31421153
[TBL] [Abstract][Full Text] [Related]
4. Interaction of EZH2 and P65 is involved in the arsenic trioxide-induced anti-angiogenesis in human triple-negative breast cancer cells.
Jiang F; Li Y; Si L; Zhang Z; Li Z
Cell Biol Toxicol; 2019 Aug; 35(4):361-371. PubMed ID: 30612216
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of EZH2 alleviates angiogenesis in a model of corneal neovascularization by blocking FoxO3a-mediated oxidative stress.
Wan SS; Pan YM; Yang WJ; Rao ZQ; Yang YN
FASEB J; 2020 Aug; 34(8):10168-10181. PubMed ID: 32562311
[TBL] [Abstract][Full Text] [Related]
6. Transient receptor potential melastatin 4 contributes to early-stage endothelial injury induced by arsenic trioxide.
Yu CX; Zhang YY; Wu XY; Tang HX; Liang XQ; Xue ZM; Xue YD; Li J; Zhu H; Huo R; Ban T
Toxicol Lett; 2019 Sep; 312():98-108. PubMed ID: 31054354
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy.
Li T; Ma R; Zhang Y; Mo H; Yang X; Hu S; Wang L; Novakovic VA; Chen H; Kou J; Bi Y; Yu B; Fang S; Wang J; Zhou J; Shi J
Cell Death Dis; 2018 Jan; 9(2):75. PubMed ID: 29362482
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide inhibits angiogenesis of hepatocellular carcinoma after insufficient radiofrequency ablation via blocking paracrine angiopoietin-1 and angiopoietin-2.
Dong S; Li Z; Kong J; Wu S; Gao J; Sun W
Int J Hyperthermia; 2022; 39(1):888-896. PubMed ID: 35848416
[TBL] [Abstract][Full Text] [Related]
9. Novel combined Ato-C treatment synergistically suppresses proliferation of Bcr-Abl-positive leukemic cells in vitro and in vivo.
Wahiduzzaman M; Ota A; Karnan S; Hanamura I; Mizuno S; Kanasugi J; Rahman ML; Hyodo T; Konishi H; Tsuzuki S; Takami A; Hosokawa Y
Cancer Lett; 2018 Oct; 433():117-130. PubMed ID: 29944906
[TBL] [Abstract][Full Text] [Related]
10. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide preferentially induces nonapoptotic cell deaths as well as actin cytoskeleton rearrangement in the CHO AA8 cell line.
Izdebska M; Klimaszewska-Wiśniewska A; Lewandowski D; Marcin Nowak J; Gagat M; Grzanka A
Postepy Hig Med Dosw (Online); 2014 Dec; 68():1492-500. PubMed ID: 25531713
[TBL] [Abstract][Full Text] [Related]
12. VEGFA Expression Is Inhibited by Arsenic Trioxide in HUVECs through the Upregulation of Ets-2 and miRNA-126.
Ge HY; Han ZJ; Tian P; Sun WJ; Xue DX; Bi Y; Yang ZH; Liu P
PLoS One; 2015; 10(8):e0135795. PubMed ID: 26274316
[TBL] [Abstract][Full Text] [Related]
13. Synergy between arsenic trioxide and JQ1 on autophagy in pancreatic cancer.
Xu C; Wang X; Zhou Y; Chen FX; Wang H; Li K; Fan H; Tang X; Jiang G; Zhang J
Oncogene; 2019 Nov; 38(47):7249-7265. PubMed ID: 31420604
[TBL] [Abstract][Full Text] [Related]
14. Realgar transforming solution suppresses angiogenesis and tumor growth by inhibiting VEGF receptor 2 signaling in vein endothelial cells.
Song P; Hai Y; Wang X; Zhao L; Chen B; Cui P; Xie Q; Yu L; Li Y; Wu Z; Li H
Arch Pharm Res; 2018 Apr; 41(4):467-480. PubMed ID: 29542005
[TBL] [Abstract][Full Text] [Related]
15. T7 peptide inhibits angiogenesis via downregulation of angiopoietin-2 and autophagy.
Wang F; Dong X; Xiu P; Zhong J; Wei H; Xu Z; Li T; Liu F; Sun X; Li J
Oncol Rep; 2015 Feb; 33(2):675-84. PubMed ID: 25483829
[TBL] [Abstract][Full Text] [Related]
16. Use of a Mouse Model and Human Umbilical Vein Endothelial Cells to Investigate the Effect of Arsenic Exposure on Vascular Endothelial Function and the Associated Role of Calpains.
Cai Z; Zhang Y; Zhang Y; Miao X; Li S; Yang H; Ling Q; Hoffmann PR; Huang Z
Environ Health Perspect; 2019 Jul; 127(7):77003. PubMed ID: 31274337
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide-induced autophagy affected the antioxidant capacity and apoptosis rate of chicken hepatocytes.
Ning Z; Lan J; Jiang X; Zhong G; Zhang H; Wan F; Wu S; Tang Z; Bilal RM; Hu L; Huang R
Chem Biol Interact; 2022 Feb; 354():109821. PubMed ID: 35051378
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide induces programmed cell death through stimulation of ER stress and inhibition of the ubiquitin-proteasome system in human sarcoma cells.
Chiu HW; Tseng YC; Hsu YH; Lin YF; Foo NP; Guo HR; Wang YJ
Cancer Lett; 2015 Jan; 356(2 Pt B):762-72. PubMed ID: 25449439
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide exerts anti-lung cancer activity by inhibiting angiogenesis.
Yang MH; Zang YS; Huang H; Chen K; Li B; Sun GY; Zhao XW
Curr Cancer Drug Targets; 2014; 14(6):557-66. PubMed ID: 25088040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]